Teva Tops Valeant With $6.8B Cephalon Buy
By Pete Brush ( May 2, 2011, 12:10 PM EDT) -- Teva Pharmaceutical Industries Ltd. swooped in to buy Cephalon Inc. on Monday in a $6.8 billion deal that blew the doors off a previously rejected $5.7 billion bid by Valeant Pharmaceuticals International Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.